On July 14, 2026, CVS Caremark settled with the FTC over the rebate machinery that sat between patients and the price of their medicine. The savings are projected in billions. The mechanism was built one prescription at a time.
For years, the price on the pharmacy receipt was not the price of the drug. It was the price of a rebate game played above the patient's head. On February 4, 2026, one of the three companies running that game agreed to stop.
By Mark Tell · May 1
Daily at 6AM Eastern
See the pitch they're running today.
Financial crime intelligence. The patterns, the tells, the playbook. Daily at 6AM before anyone asks you for money.
By subscribing you agree to receive the daily MarkTell digest. Free forever. Unsubscribe anytime.
The MarkTell Daily
Tomorrow's pitch, decoded today.
Financial crime intelligence. The patterns, the tells, the playbook. Daily at 6AM before anyone asks you for money.
By subscribing you agree to receive the daily MarkTell digest. Free forever. Unsubscribe anytime.
